NCT04900818 2026-03-05Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsI-Mab Biopharma US LimitedPhase 1 Recruiting330 enrolled
NCT07334119 2026-02-19Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsMyeloid TherapeuticsPhase 1 Recruiting60 enrolled